Pfizer Inc (PFE) Down 2.15%, Crosses 50, 100 and 200 Day Moving Averages; in a Downtrend Over Past 14 Days

Pfizer Inc Daily Price Recap

Pfizer Inc entered today at $36.4, down 2.15% ($0.8) from the day prior. The price move occurred on stronger volume; specifically, yesterday’s volume was up 23.7% from the day prior, and up 37.06% from the same day the week before. The daily price chart of Pfizer Inc below illustrates.

PFE

Pfizer Inc Technical Analysis

Moving average crossovers are always interesting, so let’s start there: Pfizer Inc crossed below its 50, 100 and 200 day moving averages yesterday. Trend traders will want to observe that the strongest trend appears on the 14 day horizon; over that time period, price has been moving down. For another vantage point, consider that Pfizer Inc’s price has gone down 8 of the previous 14 trading days.

Overheard Around the Web

Over on StockTwits, here’s an example of what they’re saying about PFE:

    $PFE Need some advice from professional option players, I just started playing options last month and still learning. My gut feeling is Pfizer will have a vaccine and get an fda approval. I want to buy 1000 Pfizer $50 call options. Pfizer may have the positive clinical data released in late October or November and FDA approval in November or December. My question is which expiration I should buy in for decent profit and safe at the Same time ? 11/20/20, 12/18,20 or 01/15/21, Considering decay in options premium , giving ample time for positive data and fda approval ? Please advice

    Nshah1